메뉴 건너뛰기




Volumn 107, Issue 7, 2007, Pages 260-269

Insulin therapy for maximal glycemic control in type 2 diabetes mellitus

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; BIGUANIDE DERIVATIVE; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLITAZONE DERIVATIVE; HUMAN INSULIN; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; MEGLITINIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA; SULFONYLUREA DERIVATIVE;

EID: 34548039229     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (10)

References (63)
  • 1
    • 34548051457 scopus 로고    scopus 로고
    • NIH Publication No. 06-3892
    • National Diabetes Statistics, November, Available at:, Accessed July 5
    • National Diabetes Statistics. NIH Publication No. 06-3892. National Diabetes Information Clearinghouse Web site. November 2005. Available at: http://diabete.niddk.nih.gov/dm/pubs/statistics/index.htm. Accessed July 5, 2007.
    • (2005) National Diabetes Information Clearinghouse Web site
  • 3
    • 32144448938 scopus 로고    scopus 로고
    • Standards of medical care in diabetes - 2006
    • American Diabetes Association, Available at:, Accessed June 14, 2007
    • American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care. 2006;29(suppl 1):S4-S42. Available at: http://care.diabetesjournals.org/cgi/content/full/29/suppl_1/s4. Accessed June 14, 2007.
    • (2006) Diabetes Care , vol.29 , Issue.SUPPL. 1
  • 4
    • 0032887833 scopus 로고    scopus 로고
    • A desktop guide to type 2 diabetes mellitus
    • European Diabetes Policy Group
    • European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet Med. 1999;16:716-730.
    • (1999) Diabet Med , vol.1999 , Issue.16 , pp. 716-730
  • 5
    • 0242269000 scopus 로고    scopus 로고
    • The treat-to-target trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    • for the Insulin Glargine Study Investigators, Available at:, Accessed June 14, 2007
    • Riddle MC, Rosenstock J, Gerich J, for the Insulin Glargine Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080-3086. Available at: http://care.diabetesjournals.org/cgi/ content/full/26/11/3080. Accessed June 14, 2007.
    • (2003) Diabetes Care , vol.26 , pp. 3080-3086
    • Riddle, M.C.1    Rosenstock, J.2    Gerich, J.3
  • 6
    • 3042793937 scopus 로고    scopus 로고
    • Improved glycemic control without weight gain using triple therapy in type 2 diabetes
    • Available at:, Accessed July 5, 2007
    • Strowig SM, Aviles-Santa ML, Raskin P. Improved glycemic control without weight gain using triple therapy in type 2 diabetes. Diabetes Care. 2004;27:1577-1583. Available at: http://care.diabetesjournals.org/cgi/content/ full/27/7/1577. Accessed July 5, 2007.
    • (2004) Diabetes Care , vol.27 , pp. 1577-1583
    • Strowig, S.M.1    Aviles-Santa, M.L.2    Raskin, P.3
  • 7
    • 1042280201 scopus 로고    scopus 로고
    • Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: A preliminary report
    • Available at:, Accessed June 14, 2007
    • Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17-20. Available at: http://care.diabetesjournals. org/cgi/content/full/27/1/17. Accessed June 14, 2007.
    • (2004) Diabetes Care , vol.27 , pp. 17-20
    • Koro, C.E.1    Bowlin, S.J.2    Bourgeois, N.3    Fedder, D.O.4
  • 8
    • 0003613373 scopus 로고
    • The National Center for Health Statistics, Hyattsville, Md: US Department of Health and Human Services;, 1997
    • The National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, Md: US Department of Health and Human Services; 1997.
    • (1988) Third National Health and Nutrition Examination Survey
  • 9
    • 0003447646 scopus 로고    scopus 로고
    • The National Center for Health Statistics, Hyattsville, Md: US Department of Health and Human Services;
    • The National Center for Health Statistics. National Health and Nutrition Examination Survey, 1999-2000. Hyattsville, Md: US Department of Health and Human Services; 2002.
    • (2002) National Health and Nutrition Examination Survey, 1999-2000
  • 10
    • 0347133334 scopus 로고    scopus 로고
    • Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
    • Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
    • (2004) JAMA , vol.291 , pp. 335-342
    • Saydah, S.H.1    Fradkin, J.2    Cowie, C.C.3
  • 11
    • 8344229187 scopus 로고    scopus 로고
    • Waiting to inhale: Noninjectable insulin, are we there yet?
    • Hermansen K. Waiting to inhale: noninjectable insulin, are we there yet? Curr Diab Rep. 2004;4:335-341.
    • (2004) Curr Diab Rep , vol.4 , pp. 335-341
    • Hermansen, K.1
  • 12
    • 0032511583 scopus 로고    scopus 로고
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602]. Lancet. 1998;352:837-853.
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602]. Lancet. 1998;352:837-853.
  • 13
    • 0031018185 scopus 로고    scopus 로고
    • NIDDM patients' fears and hopes about insulin therapy: The basis of patient reluctance
    • Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care. 1997;20:292-298.
    • (1997) Diabetes Care , vol.20 , pp. 292-298
    • Hunt, L.M.1    Valenzuela, M.A.2    Pugh, J.A.3
  • 14
    • 0036736185 scopus 로고    scopus 로고
    • When oral agents fail: Practical barriers to starting insulin
    • Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(suppl 3):S18-S24.
    • (2002) Int J Obes Relat Metab Disord , vol.26 , Issue.SUPPL. 3
    • Korytkowski, M.1
  • 15
    • 0024455816 scopus 로고
    • Doctors' beliefs and the management of insulin dependent diabetes: Implications for sharing care
    • Kinmonth AL, Marteau TM. Doctors' beliefs and the management of insulin dependent diabetes: implications for sharing care. Fam Pract. 1989;6:193-198.
    • (1989) Fam Pract , vol.6 , pp. 193-198
    • Kinmonth, A.L.1    Marteau, T.M.2
  • 16
    • 0035093975 scopus 로고    scopus 로고
    • The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes: The QuED Study Group - quality of care and outcomes in type 2 diabetes
    • for the QuED Study Group Writing Committee Coordinating Center, Available at:, Accessed June 14, 2007
    • Belfiglio M, De Berardis G, Franciosi M, Cavaliere D, Di Nardo B, Greenfield S, et al, for the QuED Study Group Writing Committee Coordinating Center. The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes: The QuED Study Group - quality of care and outcomes in type 2 diabetes. Diabetes Care. 2001;24:423-429. Available at: http://care.diabetesjournals.org/cgi/content/ full/24/3/423. Accessed June 14, 2007.
    • (2001) Diabetes Care , vol.24 , pp. 423-429
    • Belfiglio, M.1    De Berardis, G.2    Franciosi, M.3    Cavaliere, D.4    Di Nardo, B.5    Greenfield, S.6
  • 17
    • 0003191727 scopus 로고    scopus 로고
    • The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE system of intensive diabetes self-management - 2002 update
    • American Association of Clinical Endocrinologists
    • American Association of Clinical Endocrinologists. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management - 2002 update. Endocr Pract. 2002;8(suppl 1):40-82.
    • (2002) Endocr Pract , vol.8 , Issue.SUPPL. 1 , pp. 40-82
  • 18
    • 3042685448 scopus 로고    scopus 로고
    • Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance
    • Durbin RJ. Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance. Diabetes Obes Metab. 2004;6:280-285.
    • (2004) Diabetes Obes Metab , vol.6 , pp. 280-285
    • Durbin, R.J.1
  • 19
    • 0036724346 scopus 로고    scopus 로고
    • Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
    • Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-2803.
    • (2002) Diabetes , vol.51 , pp. 2796-2803
    • Buchanan, T.A.1    Xiang, A.H.2    Peters, R.K.3    Kjos, S.L.4    Marroquin, A.5    Goico, J.6
  • 20
    • 34548042631 scopus 로고    scopus 로고
    • Texas Diabetes Council, Publication #45-11265. Texas Department of State Health Services. Revised April 27, Available at:, Accessed June 18
    • Texas Diabetes Council. Glycemic control algorithm for type 2 diabetes mellitus in children and adults. Publication #45-11265. Texas Department of State Health Services. Revised April 27, 2006. Available at: http://www.dshs.state.tx.us/diabetes/PDF/algorithms/PHARM2.PDF. Accessed June 18, 2007.
    • (2006) Glycemic control algorithm for type 2 diabetes mellitus in children and adults
  • 21
    • 34548024031 scopus 로고    scopus 로고
    • Bergenstal RM, Kendall DM, Franz MJ, Rubenstein AH. Management of type 2 diabetes: a systematic approach to meeting the standards of care. II: oral agents, insulin, and management of complications. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, Pa: WB Saunders Co; 2001:821-835.
    • Bergenstal RM, Kendall DM, Franz MJ, Rubenstein AH. Management of type 2 diabetes: a systematic approach to meeting the standards of care. II: oral agents, insulin, and management of complications. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, Pa: WB Saunders Co; 2001:821-835.
  • 23
    • 0031878264 scopus 로고    scopus 로고
    • Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe
    • Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998;20:486-496.
    • (1998) Clin Ther , vol.20 , pp. 486-496
    • Graff, M.R.1    McClanahan, M.A.2
  • 24
    • 0344233275 scopus 로고    scopus 로고
    • A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus
    • for the FlexPen Study Team
    • Korytkowski M, Bell D, Jacobsen C, Suwannasari R, for the FlexPen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003;25:2836-2848.
    • (2003) Clin Ther , vol.25 , pp. 2836-2848
    • Korytkowski, M.1    Bell, D.2    Jacobsen, C.3    Suwannasari, R.4
  • 25
    • 26944435504 scopus 로고    scopus 로고
    • Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: A randomized, controlled trial
    • Available at:, Accessed June 18, 2007
    • Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2005;143:549-558. Available at: http://www.annals.org/ cgi/content/full/143/8/549. Accessed June 18, 2007.
    • (2005) Ann Intern Med , vol.143 , pp. 549-558
    • Rosenstock, J.1    Zinman, B.2    Murphy, L.J.3    Clement, S.C.4    Moore, P.5    Bowering, C.K.6
  • 26
    • 23044488164 scopus 로고    scopus 로고
    • Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: A 12-week, randomized, comparative trial
    • for the Exubera Phase III Study Group, Available at:, Accessed June 14, 2007
    • DeFronzo RA, Bergenstal RM, Cefalu WT, Pullman J, Lerman S, Bode BW, et al, for the Exubera Phase III Study Group. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care. 2005;28:1922-1928. Available at: http://care.diabetesjournals.org/cgi/content/full/28/8/1922. Accessed June 14, 2007.
    • (2005) Diabetes Care , vol.28 , pp. 1922-1928
    • DeFronzo, R.A.1    Bergenstal, R.M.2    Cefalu, W.T.3    Pullman, J.4    Lerman, S.5    Bode, B.W.6
  • 27
    • 0032839780 scopus 로고    scopus 로고
    • Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The Barilla factory revisited
    • Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E, et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism. 1999;48:989-994.
    • (1999) Metabolism , vol.48 , pp. 989-994
    • Zavaroni, I.1    Bonini, L.2    Gasparini, P.3    Barilli, A.L.4    Zuccarelli, A.5    Dall'Aglio, E.6
  • 28
    • 0029957413 scopus 로고    scopus 로고
    • Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
    • Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39:1577-1583.
    • (1996) Diabetologia , vol.39 , pp. 1577-1583
    • Hanefeld, M.1    Fischer, S.2    Julius, U.3    Schulze, J.4    Schwanebeck, U.5    Schmechel, H.6
  • 29
    • 0034641568 scopus 로고    scopus 로고
    • UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
    • Available at:, Accessed July 19, 2007
    • Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al; UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412. Available at: http://www.bmj.com/cgi/content/full/321/7258/405. Accessed July 19, 2007.
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.W.3    Matthews, D.R.4    Manley, S.E.5    Cull, C.A.6
  • 30
    • 0030974812 scopus 로고    scopus 로고
    • Malmberg K, for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515. Available at: http://www.bmj.com/cgi/content/full/314/7093/1512. Accessed July 19, 2007.
    • Malmberg K, for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515. Available at: http://www.bmj.com/cgi/content/full/314/7093/1512. Accessed July 19, 2007.
  • 31
    • 0033055724 scopus 로고    scopus 로고
    • Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
    • Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999;353:617-622.
    • (1999) Lancet , vol.353 , pp. 617-622
    • Gaede, P.1    Vedel, P.2    Parving, H.H.3    Pedersen, O.4
  • 32
    • 0009766506 scopus 로고    scopus 로고
    • Negotiating the barrier of hypoglycemia in diabetes
    • Available at:, Accessed June 18, 2007
    • Cryer PE, Childs BP. Negotiating the barrier of hypoglycemia in diabetes. Diabetes Spectrum. 2002;15:20-27. Available at: http://spectrum. diabetesjournals.org/content/vol15/issue1/. Accessed June 18, 2007.
    • (2002) Diabetes Spectrum , vol.15 , pp. 20-27
    • Cryer, P.E.1    Childs, B.P.2
  • 33
    • 85136436269 scopus 로고    scopus 로고
    • Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization [published correction appears in JAMA. 1999;281:1989]. JAMA. 1997;278:1663-1669.
    • Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization [published correction appears in JAMA. 1999;281:1989]. JAMA. 1997;278:1663-1669.
  • 34
    • 0028817815 scopus 로고    scopus 로고
    • UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease [published correction appears in Diabetes. 1996;45:1655]. Diabetes. 1995;44:1249-1258.
    • UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease [published correction appears in Diabetes. 1996;45:1655]. Diabetes. 1995;44:1249-1258.
  • 36
    • 0034968632 scopus 로고    scopus 로고
    • Hypoglycemia risk reduction in type 1 diabetes
    • Cryer PE. Hypoglycemia risk reduction in type 1 diabetes. Exp Clin Endocrinol Diab. 2001;109(suppl 2):S412-S423.
    • (2001) Exp Clin Endocrinol Diab , vol.109 , Issue.SUPPL. 2
    • Cryer, P.E.1
  • 37
    • 0038336648 scopus 로고    scopus 로고
    • Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in type 2 diabetic patients
    • HOE 901/2004 Study Investigators Group
    • HOE 901/2004 Study Investigators Group. Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in type 2 diabetic patients. Diabet Med. 2003;20:545-551.
    • (2003) Diabet Med , vol.20 , pp. 545-551
  • 38
    • 12844276465 scopus 로고    scopus 로고
    • Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
    • Available at:, Accessed June 14, 2007
    • Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care. 2005;28:254-259. Available at: http://care. diabetesjournals.org/cgi/content/full/28/2/254. Accessed June 14, 2007.
    • (2005) Diabetes Care , vol.28 , pp. 254-259
    • Janka, H.U.1    Plewe, G.2    Riddle, M.C.3    Kliebe-Frisch, C.4    Schweitzer, M.A.5    Yki-Järvinen, H.6
  • 39
    • 0038131919 scopus 로고    scopus 로고
    • 4001 Study Group. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: A randomized, controlled trial
    • Available at:, Accessed June 18, 2007
    • Fritsche A, Schweitzer MA, Häring H-U; 4001 Study Group. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2003;138:952-959. Available at: http://www.annals.org/cgi/content/full/138/12/952. Accessed June 18, 2007.
    • (2003) Ann Intern Med , vol.138 , pp. 952-959
    • Fritsche, A.1    Schweitzer, M.A.2    Häring, H.-U.3
  • 40
    • 0033867021 scopus 로고    scopus 로고
    • Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes
    • for the HOE 901-3002 Study Group, Available at:, Accessed June 14, 2007
    • Yki-Järvinen H, Dressler A, Ziemen M, for the HOE 901-3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care. 2000;23:1130-1136. Available at: http://care.diabetesjournals.org/cgi/reprint/23/8/1130. Accessed June 14, 2007.
    • (2000) Diabetes Care , vol.23 , pp. 1130-1136
    • Yki-Järvinen, H.1    Dressler, A.2    Ziemen, M.3
  • 41
    • 0037737732 scopus 로고    scopus 로고
    • Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: Scientific review
    • DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003;289:2254-2264.
    • (2003) JAMA , vol.289 , pp. 2254-2264
    • DeWitt, D.E.1    Hirsch, I.B.2
  • 42
    • 0642333660 scopus 로고    scopus 로고
    • Management of diabetes in the real world: Tight control of glucose metabolism
    • Available at:, Accessed June 18, 2007
    • Spellman CW. Management of diabetes in the real world: tight control of glucose metabolism. J Am Osteopath Assoc. 2003;103(suppl 5):S8-S13. Available at: http://www.jaoa.org/cgi/reprint/103/8_suppl_5/S8. Accessed June 18, 2007
    • (2003) J Am Osteopath Assoc , vol.103 , Issue.SUPPL. 5
    • Spellman, C.W.1
  • 43
    • 19944368427 scopus 로고    scopus 로고
    • LANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: Comparison of two treatment algorithms using insulin glargine
    • Available at:, Accessed June 14, 2007
    • Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R, for the AT.LANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care. 2005;28:1282-1288. Available at: http://care.diabetesjournals.org/cgi/content/full/28/6/1282. Accessed June 14, 2007.
    • (2005) Diabetes Care , vol.28 , pp. 1282-1288
    • Davies, M.1    Storms, F.2    Shutler, S.3    Bianchi-Biscay, M.4    Gomis, R.5    for the, A.T.6
  • 44
    • 34548023785 scopus 로고    scopus 로고
    • Texas Diabetes Council, Publication #45-11647. Texas Department of State Health Services. Revised October 20, Available at:, Accessed June 18
    • Texas Diabetes Council. Insulin algorithm for type 2 diabetes mellitus in children and adults. Publication #45-11647. Texas Department of State Health Services. Revised October 20, 2005. Available at: http://www.dshs.state.tx.us/ diabetes/PDF/algorithms/INST2.pdf. Accessed June 18, 2007.
    • (2005) Insulin algorithm for type 2 diabetes mellitus in children and adults
  • 46
    • 6944244979 scopus 로고    scopus 로고
    • Raslovà K, Bogoev M, Raz I, Leth G, Gall MA, Hâncu N. Insulin detemir and insulin aspart: a promising basal bolus regimen for type 2 diabetes [published correction appears in Diabetes Res Clin Pract. 2006;72:112]. Diabetes Res Clin Pract. 2004;66:193-201.
    • Raslovà K, Bogoev M, Raz I, Leth G, Gall MA, Hâncu N. Insulin detemir and insulin aspart: a promising basal bolus regimen for type 2 diabetes [published correction appears in Diabetes Res Clin Pract. 2006;72:112]. Diabetes Res Clin Pract. 2004;66:193-201.
  • 47
    • 4143128768 scopus 로고    scopus 로고
    • Managing obesity and glycemic control in insulin-using patients: Clinical relevance and practice recommendations
    • Gottesman I. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations. Diabetes Res Clin Pract. 2004;65(suppl 1):S17-S22.
    • (2004) Diabetes Res Clin Pract , vol.65 , Issue.SUPPL. 1
    • Gottesman, I.1
  • 48
    • 0344609217 scopus 로고    scopus 로고
    • Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus
    • Mäkimattila S, Nikkilä K, Yki-Järvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia. 1999;42:406-412.
    • (1999) Diabetologia , vol.42 , pp. 406-412
    • Mäkimattila, S.1    Nikkilä, K.2    Yki-Järvinen, H.3
  • 49
    • 0035486744 scopus 로고    scopus 로고
    • Insulin therapy does not itself induce weight gain in patients with type 2 diabetes
    • Available at:, Accessed June 14, 2007
    • Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Insulin therapy does not itself induce weight gain in patients with type 2 diabetes. Diabetes Care. 2001;24:1849-1850. Available at: http://care.diabetesjournals.org/cgi/ content/full/24/10/1849. Accessed June 14, 2007.
    • (2001) Diabetes Care , vol.24 , pp. 1849-1850
    • Larger, E.1    Rufat, P.2    Dubois-Laforgue, D.3    Ledoux, S.4
  • 51
    • 0032700367 scopus 로고    scopus 로고
    • Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus
    • Yki-Järvinen H, Nikkilä K, Mäkimattila S. Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs. 1999;58(suppl 1):53-54,75-82.
    • (1999) Drugs , vol.58 , Issue.SUPPL. 1
    • Yki-Järvinen, H.1    Nikkilä, K.2    Mäkimattila, S.3
  • 52
    • 0345425783 scopus 로고    scopus 로고
    • Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
    • Available at:, Accessed June 18, 2007
    • Avilés-Santa L, Sinding J, Raskin P. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131:182-188. Available at: http://www.annals.org/cgi/content/full/131/3/ 182. Accessed June 18, 2007.
    • (1999) Ann Intern Med , vol.131 , pp. 182-188
    • Avilés-Santa, L.1    Sinding, J.2    Raskin, P.3
  • 53
    • 0346219295 scopus 로고    scopus 로고
    • Effect of thiazolidinediones on body weight in patients with diabetes mellitus
    • Fonseca V. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med. 2003;115(suppl 8A):42S-48S.
    • (2003) Am J Med , vol.115 , Issue.SUPPL. 8A
    • Fonseca, V.1
  • 54
    • 0033925345 scopus 로고    scopus 로고
    • Comparison of insulin regimens for patients with type 2 diabetes
    • Yki-Järvinen H. Comparison of insulin regimens for patients with type 2 diabetes. Curr Opin Endocrinol Diabetes. 2000;7:175-183.
    • (2000) Curr Opin Endocrinol Diabetes , vol.7 , pp. 175-183
    • Yki-Järvinen, H.1
  • 55
    • 26944477362 scopus 로고    scopus 로고
    • Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: A randomized trial
    • for the GWAA Study Group, Available at:, Accessed June 18, 2007
    • Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG, for the GWAA Study Group. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med. 2005;143:559-569. Available at: http://www.annals.org/cgi/content/full/ 143/8/559. Accessed June 18, 2007.
    • (2005) Ann Intern Med , vol.143 , pp. 559-569
    • Heine, R.J.1    Van Gaal, L.F.2    Johns, D.3    Mihm, M.J.4    Widel, M.H.5    Brodows, R.G.6
  • 56
    • 12744274870 scopus 로고    scopus 로고
    • Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
    • Haak T, Tiengo A, Draeger E, Suntum W, Waldhäusl W. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab. 2005;7:56-64.
    • (2005) Diabetes Obes Metab , vol.7 , pp. 56-64
    • Haak, T.1    Tiengo, A.2    Draeger, E.3    Suntum, W.4    Waldhäusl, W.5
  • 57
    • 0002295222 scopus 로고    scopus 로고
    • Advantages of adding metformin to multiple dose insulin therapy in type 2 diabetes [abstract 0347]
    • Bergenstal R, Johnson M, Whipple D, et al. Advantages of adding metformin to multiple dose insulin therapy in type 2 diabetes [abstract 0347]. Diabetes. 1998;47(suppl 1):A89.
    • (1998) Diabetes , vol.47 , Issue.SUPPL. 1
    • Bergenstal, R.1    Johnson, M.2    Whipple, D.3
  • 58
    • 0028966408 scopus 로고
    • Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients
    • Chow CC, Tsang LW, Sorensen JP, Cockram CS. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes Care. 1995;18:307-314.
    • (1995) Diabetes Care , vol.18 , pp. 307-314
    • Chow, C.C.1    Tsang, L.W.2    Sorensen, J.P.3    Cockram, C.S.4
  • 59
    • 0029067658 scopus 로고
    • Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM
    • Cusi K, Cunningham GR, Comstock JP. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care. 1995;18:843-851.
    • (1995) Diabetes Care , vol.18 , pp. 843-851
    • Cusi, K.1    Cunningham, G.R.2    Comstock, J.P.3
  • 60
    • 0029123497 scopus 로고
    • Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure
    • Landstedt-Hallin L, Adamson U, Arner P, Bolinder J, Lins PE. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure. Diabetes Care. 1995;18:1183-1186.
    • (1995) Diabetes Care , vol.18 , pp. 1183-1186
    • Landstedt-Hallin, L.1    Adamson, U.2    Arner, P.3    Bolinder, J.4    Lins, P.E.5
  • 61
    • 0034827469 scopus 로고    scopus 로고
    • Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin
    • Available at:, Accessed June 14, 2007
    • Rosenstock J, Schwartz SL, Clark Jr CM, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care. 2001;24:631-636. Available at: http://care.diabetesjournals.org/cgi/content/full/24/4/631. Accessed June 14, 2007.
    • (2001) Diabetes Care , vol.24 , pp. 631-636
    • Rosenstock, J.1    Schwartz, S.L.2    Clark Jr, C.M.3    Park, G.D.4    Donley, D.W.5    Edwards, M.B.6
  • 62
    • 0343724362 scopus 로고    scopus 로고
    • Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: A randomized, controlled trial
    • Available at:, Accessed June 18, 2007
    • Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1999;130:389-396. Available at: http://www.annals.org/cgi/content/full/130/5/ 389. Accessed June 18, 2007.
    • (1999) Ann Intern Med , vol.130 , pp. 389-396
    • Yki-Järvinen, H.1    Ryysy, L.2    Nikkilä, K.3    Tulokas, T.4    Vanamo, R.5    Heikkilä, M.6
  • 63
    • 18144401971 scopus 로고    scopus 로고
    • Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
    • DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care. 2005;28:1092-1100.
    • (2005) Diabetes Care , vol.28 , pp. 1092-1100
    • DeFronzo, R.A.1    Ratner, R.E.2    Han, J.3    Kim, D.D.4    Fineman, M.S.5    Baron, A.D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.